Literature DB >> 27421979

Serum angiotensin-converting enzyme 2 concentration and angiotensin-(1-7) concentration in patients with acute heart failure patients requiring emergency hospitalization.

Shinji Hisatake1, Shunsuke Kiuchi2, Takayuki Kabuki2, Takashi Oka2, Shintaro Dobashi2, Takanori Ikeda2.   

Abstract

The existence of a new cascade, angiotensin-converting enzyme (ACE) 2/angiotensin (Ang)-(1-7)/Mas receptor axis, has been recently established in the renin-angiotensin system. However, the dynamics of this cascade under various pathological conditions in clinical settings is still unclear. Forty-nine patients who underwent emergency hospitalization because of acute heart failure (AHF) consented to participate in this study. Thirty-eight healthy volunteers served as controls. Serum ACE activity, ACE2, Ang-(1-7) concentration, plasma Ang II, aldosterone concentration, and plasma renin activity (PRA) were measured at the acute stage. We conducted a comparative study between patients with AHF and healthy volunteers. Patients with AHF showed lower serum ACE activity and plasma aldosterone concentration than healthy volunteers (12.3 vs. 15.1 IU/L, respectively; P = 0.01, 75.6 vs. 125.3 pg/mL, respectively; P = 0.000); there were no differences between the two groups in PRA and plasma Ang II concentration. Patients with AHF had a higher serum ACE2 concentration than healthy volunteers (7.9 vs. 4.8 ng/mL, respectively; P = 0.002), but their serum Ang-(1-7) concentration was significantly lower (2.4 vs 3.1 ng/mL, respectively; P = 0.005). Patients with AHF had a higher serum ACE2 concentration, lower serum Ang-(1-7) concentration, and lower serum ACE activity and plasma aldosterone concentrations than healthy volunteers, whereas PRA and plasma Ang II concentration were the same.

Entities:  

Keywords:  Angiotensin-(1–7); Angiotensin-converting enzyme 2; Patients with AHF

Mesh:

Substances:

Year:  2016        PMID: 27421979     DOI: 10.1007/s00380-016-0877-z

Source DB:  PubMed          Journal:  Heart Vessels        ISSN: 0910-8327            Impact factor:   2.037


  27 in total

1.  Measurement of immunoreactive angiotensin-(1-7) heptapeptide in human blood.

Authors:  J Nussberger; D B Brunner; J A Nyfeler; L Linder; H R Brunner
Journal:  Clin Chem       Date:  2001-04       Impact factor: 8.327

2.  An ACE in the hole alternative pathways of the renin angiotensin system and their potential role in cardiac remodeling.

Authors:  Barry Greenberg
Journal:  J Am Coll Cardiol       Date:  2008-08-26       Impact factor: 24.094

Review 3.  ACE2-angiotensin-(1-7)-Mas axis and oxidative stress in cardiovascular disease.

Authors:  Luiza A Rabelo; Natalia Alenina; Michael Bader
Journal:  Hypertens Res       Date:  2010-12-02       Impact factor: 3.872

4.  Plasma renin activity in the emergency department and its independent association with acute myocardial infarction.

Authors:  J D Blumenfeld; J E Sealey; M H Alderman; H Cohen; R Lappin; D F Catanzaro; J H Laragh
Journal:  Am J Hypertens       Date:  2000-08       Impact factor: 2.689

5.  Plasma and Kidney Angiotensin Peptides: Importance of the Aminopeptidase A/Angiotensin III Axis.

Authors:  Jan Wysocki; Minghao Ye; Daniel Batlle
Journal:  Am J Hypertens       Date:  2015-05-11       Impact factor: 2.689

Review 6.  Regulation of angiotensin II receptors beyond the classical pathway.

Authors:  Masatsugu Horiuchi; Jun Iwanami; Masaki Mogi
Journal:  Clin Sci (Lond)       Date:  2012-08-01       Impact factor: 6.124

7.  Targeting the degradation of angiotensin II with recombinant angiotensin-converting enzyme 2: prevention of angiotensin II-dependent hypertension.

Authors:  Jan Wysocki; Minghao Ye; Eva Rodriguez; Francisco R González-Pacheco; Clara Barrios; Karla Evora; Manfred Schuster; Hans Loibner; K Bridget Brosnihan; Carlos M Ferrario; Josef M Penninger; Daniel Batlle
Journal:  Hypertension       Date:  2009-11-30       Impact factor: 10.190

8.  Effects of enalapril on mortality in severe congestive heart failure. Results of the Cooperative North Scandinavian Enalapril Survival Study (CONSENSUS).

Authors: 
Journal:  N Engl J Med       Date:  1987-06-04       Impact factor: 91.245

9.  Converting enzyme determines plasma clearance of angiotensin-(1-7).

Authors:  K Yamada; S N Iyer; M C Chappell; D Ganten; C M Ferrario
Journal:  Hypertension       Date:  1998-09       Impact factor: 10.190

Review 10.  Therapeutic implications of the vasoprotective axis of the renin-angiotensin system in cardiovascular diseases.

Authors:  Anderson J Ferreira; Robson A S Santos; Chastity N Bradford; Adam P Mecca; Colin Sumners; Michael J Katovich; Mohan K Raizada
Journal:  Hypertension       Date:  2009-12-28       Impact factor: 10.190

View more
  6 in total

1.  Molecular remodeling of the renin-angiotensin system after kidney transplantation.

Authors:  Marlies Antlanger; Oliver Domenig; Johannes J Kovarik; Christopher C Kaltenecker; Chantal Kopecky; Marko Poglitsch; Marcus D Säemann
Journal:  J Renin Angiotensin Aldosterone Syst       Date:  2017 Apr-Jun       Impact factor: 1.636

Review 2.  Angiotensin II Signal Transduction: An Update on Mechanisms of Physiology and Pathophysiology.

Authors:  Steven J Forrester; George W Booz; Curt D Sigmund; Thomas M Coffman; Tatsuo Kawai; Victor Rizzo; Rosario Scalia; Satoru Eguchi
Journal:  Physiol Rev       Date:  2018-07-01       Impact factor: 37.312

3.  Cardioprotective effect of thyroid hormone is mediated by AT2 receptor and involves nitric oxide production via Akt activation in mice.

Authors:  Ivson Bezerra da Silva; Dayane Aparecida Gomes; Natalia Alenina; Michael Bader; Robson Augusto Dos Santos; Maria Luiza M Barreto-Chaves
Journal:  Heart Vessels       Date:  2017-12-07       Impact factor: 2.037

4.  Angiotensin II induces apoptosis of cardiac microvascular endothelial cells via regulating PTP1B/PI3K/Akt pathway.

Authors:  Yanyan Wang; Yuyuan Fan; Yu Song; Xueting Han; Mingqiang Fu; Jingfeng Wang; Xiaotong Cui; Juan Cao; Li Chen; Kai Hu; Aijun Sun; Jingmin Zhou; Junbo Ge
Journal:  In Vitro Cell Dev Biol Anim       Date:  2019-09-09       Impact factor: 2.416

5.  The serum angiotensin-converting enzyme 2 and angiotensin-(1-7) concentrations after optimal therapy for acute decompensated heart failure with reduced ejection fraction.

Authors:  Shinji Hisatake; Shunsuke Kiuchi; Takayuki Kabuki; Takashi Oka; Shintaro Dobashi; Takahiro Fujii; Takanori Ikeda
Journal:  Biosci Rep       Date:  2020-06-26       Impact factor: 3.840

Review 6.  Multifunctional angiotensin converting enzyme 2, the SARS-CoV-2 entry receptor, and critical appraisal of its role in acute lung injury.

Authors:  Murat Oz; Dietrich Ernst Lorke
Journal:  Biomed Pharmacother       Date:  2021-01-05       Impact factor: 6.529

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.